Fingerprint
Dive into the research topics of 'Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically